Management of Antithrombotic Therapy After CABG
Post-CABG Antithrombotic Management
- The European Society of Cardiology recommends aspirin 75-100 mg daily as lifelong antiplatelet therapy after CABG, to be initiated as soon as there is no concern over bleeding 2, 3
- Aspirin should be restarted as soon as possible after CABG, potentially within 24 hours if bleeding risk is acceptable, as suggested by the European Heart Journal 4
- P2Y12 inhibitors, such as clopidogrel, should generally be stopped before CABG and not routinely restarted immediately post-CABG, according to the European Heart Journal and Circulation 4, 5
Timing of Anticoagulation
- Low Molecular Weight Heparin, like tinzaparin, should be discontinued 12-24 hours before CABG and replaced with unfractionated heparin per institutional practice, as recommended by Circulation 6, 5
Bleeding Risk Considerations
- Continuous telemetry is typically used in the immediate post-CABG period to monitor for arrhythmias, and the presence of CTT suggests the patient is still in the early post-operative period where bleeding risk is highest, according to the European Heart Journal 2, 7
Special Circumstances
- Dual antiplatelet therapy with aspirin and clopidogrel may be considered in selected patients at greater risk of graft occlusion and low risk of bleeding, but not in the immediate post-operative period, as suggested by the European Heart Journal 3
- A meta-analysis showed that ticagrelor-based DAPT provided superior vein graft patency compared to aspirin alone, but with increased bleeding rates, according to the European Heart Journal 4
- For patients who develop atrial fibrillation after CABG, the impact of early oral anticoagulation initiation remains unclear, as reported by the European Heart Journal 7
- Consider adding a proton pump inhibitor to reduce gastrointestinal bleeding risk if antithrombotic therapy is necessary, as recommended by the European Heart Journal 3